| Product Code: ETC339601 | Publication Date: Aug 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States (US) Placenta Market was estimated at USD 184 Million in 2025 and is projected to reach USD 218 Million by 2032, growing at a CAGR of 2.5% from 2026 to 2032. This growth trajectory is primarily driven by the rising consumer interest in the health benefits associated with placenta products, particularly among new mothers. Increased awareness regarding natural wellness solutions, alongside a growing trend in the cosmetic and pharmaceutical sectors, fuels the demand for placenta-derived items.
This graph highlights how the United States (US) Placenta Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -0.8% | decreased consumer interest in wellness |
| 2022 | 5.8% | rising popularity among health enthusiasts |
| 2023 | 3.3% | increased investment in research initiatives |
| 2024 | 3.5% | growing demand for natural supplements |
| 2025 | 3.5% | expansion of e-commerce distribution channels |
| 2026 | 2.9% | increased awareness of health benefits |
| 2027 | 3.1% | growing partnerships with wellness brands |
| 2028 | 2.9% | surge in holistic health practices |
| 2029 | 2.9% | expansion into new market segments |
| 2030 | 2.3% | increased focus on premium products |
| 2031 | 2.2% | stronger distribution network expansion |
| 2032 | 2.8% | rising interest in alternative therapies |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
In the United States, the placenta market is witnessing heightened interest in placenta encapsulation services, a process where the placenta is dehydrated and transformed into pill form for postpartum consumption. This service is becoming increasingly popular among new mothers, driven by the belief that it enhances energy levels, improves mood, and aids in hormonal balance.
Moreover, the cosmetics industry is tapping into placenta-derived ingredients for their perceived anti-aging and skin rejuvenating properties. The integration of bioactive compounds found in placenta extracts reflects a significant trend, aligning with the consumer demand for natural and effective beauty solutions.
Despite its potential, the United States placenta market faces notable restraints. Regulatory restrictions imposed by the FDA regarding the processing and distribution of placenta products for consumption or cosmetic use pose hurdles to market entry and expansion. Additionally, the absence of standardized guidelines and quality control measures in processing facilities leads to variability in product quality, ultimately impacting consumer confidence. Moreover, lingering stigmas associated with placenta consumption hinder potential market growth, necessitating educational initiatives to mitigate misconceptions and foster acceptance.
Current trends in the US placenta market are shaping a landscape characterized by a notable shift toward holistic wellness. The trend of placenta encapsulation is fueled by anecdotal evidence of health benefits during the postpartum period. Furthermore, the rise in popularity of placenta-derived skincare products points to an expanding recognition of natural ingredients in the beauty industry. As consumers become increasingly aware of the potential advantages offered by placenta-based formulations, the demand is expected to surge, fostering innovation in product development.
The placenta market in the United States presents lucrative investment opportunities across multiple sectors. In pharmaceuticals, placenta-derived products are gaining traction for their potential therapeutic applications in areas like wound healing and tissue regeneration. The cosmetics sector is embracing placenta extracts for their anti-aging properties, while regenerative medicine shows promise as researchers explore the potential of placenta-derived stem cells for treating various ailments. Stakeholders have the opportunity to collaborate with organizations engaged in the research and commercialization of placenta-derived products, thereby tapping into this dynamic market.
Government policies regarding the US placenta market focus primarily on ensuring the safety and quality of human placental tissue processing and distribution. The FDA plays a crucial role in regulating human cell and tissue-based products, including placental tissues, to prevent health risks associated with infectious diseases. Compliance with Good Tissue Practice regulations is mandatory for facilities involved in placental tissue processing. Additionally, state health departments may implement specific guidelines related to the collection and use of placental tissue for medical purposes, aimed at protecting public health and ensuring responsible utilization.
Looking ahead to 2026-2032, the United States placenta market is on track for significant expansion as consumer demand for natural health products continues to rise. Advancements in biotechnology and ongoing research into placenta-derived therapies will likely drive innovative solutions in healthcare and beauty. As education initiatives mitigate misconceptions about placenta products, market acceptance is expected to improve. Consequently, with an increasing number of companies entering the arena, the placenta market is set to flourish across diverse sectors, firmly establishing its place in the wellness landscape.
Recent developments in the US placenta market include heightened research initiatives aimed at better understanding the health benefits of placenta-derived products. This is paired with an increasing number of startups focused on innovative placenta encapsulation processes and skincare formulations. In addition, consumer feedback is being actively incorporated into product development, allowing for tailored solutions that address specific consumer needs. Overall, these trends indicate a robust interest in enhancing the quality and efficacy of placenta products in the marketplace.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Placenta Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Placenta Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Placenta Market - Industry Life Cycle |
3.4 United States (US) Placenta Market - Porter's Five Forces |
3.5 United States (US) Placenta Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 United States (US) Placenta Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 United States (US) Placenta Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing awareness and acceptance of placenta-based products for their potential health benefits. |
4.2.2 Increasing demand for natural and organic skincare and beauty products in the US. |
4.2.3 Rising interest in alternative and holistic health remedies among consumers. |
4.3 Market Restraints |
4.3.1 Regulatory challenges and concerns surrounding the safety and efficacy of placenta-derived products. |
4.3.2 Limited scientific research and conclusive evidence on the benefits of placenta-based products. |
4.3.3 Potential ethical and cultural barriers associated with the use of placenta in consumer products. |
5 United States (US) Placenta Market Trends |
6 United States (US) Placenta Market, By Types |
6.1 United States (US) Placenta Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Placenta Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 United States (US) Placenta Market Revenues & Volume, By Porcine, 2022-2032F |
6.1.4 United States (US) Placenta Market Revenues & Volume, By Equine, 2022-2032F |
6.1.5 United States (US) Placenta Market Revenues & Volume, By Ovine, 2022-2032F |
6.1.6 United States (US) Placenta Market Revenues & Volume, By Others, 2022-2032F |
6.2 United States (US) Placenta Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Placenta Market Revenues & Volume, By Pharmaceuticals, 2022-2032F |
6.2.3 United States (US) Placenta Market Revenues & Volume, By Cosmetics, 2022-2032F |
6.2.4 United States (US) Placenta Market Revenues & Volume, By Supplements, 2022-2032F |
6.2.5 United States (US) Placenta Market Revenues & Volume, By Others, 2022-2032F |
7 United States (US) Placenta Market Import-Export Trade Statistics |
7.1 United States (US) Placenta Market Export to Major Countries |
7.2 United States (US) Placenta Market Imports from Major Countries |
8 United States (US) Placenta Market Key Performance Indicators |
8.1 Consumer perception and acceptance of placenta-based products through surveys and focus groups. |
8.2 Number of clinical trials and research studies conducted on placenta-derived products. |
8.3 Trends in consumer preferences towards natural and holistic health products in the US market. |
9 United States (US) Placenta Market - Opportunity Assessment |
9.1 United States (US) Placenta Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 United States (US) Placenta Market Opportunity Assessment, By Application, 2022 & 2032F |
10 United States (US) Placenta Market - Competitive Landscape |
10.1 United States (US) Placenta Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Placenta Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here